RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.88%
This Fund
S&P 500
1 Year Est. Return
+18.88%
AUM
$214M
AUM Growth
-$18.4M
(-7.9%)
Holding
759
Top Buys
| 1 | +$3.58M | |
| 2 | +$3.45M | |
| 3 | +$3.41M | |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$2.34M |
| 5 |
TSMC
TSM
|
+$2.33M |
Top Sells
| 1 | +$2.7M | |
| 2 | +$2.67M | |
| 3 | +$2.47M | |
| 4 |
Charles Schwab
SCHW
|
+$2.47M |
| 5 |
Consolidated Edison
ED
|
+$2.22M |
Sector Composition
| 1 | Financials | 19.27% |
| 2 | Technology | 18.98% |
| 3 | Industrials | 15.06% |
| 4 | Healthcare | 10.83% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Xeris Biopharma Holdings
XERS
$1.11B
| – | – |
-12,709
|
|
||
752
Xerox
XRX
$332M
| – | – |
-14,197
|
|
||
|
MRX
753
Marex Group
MRX
$4.19B
| – | – |
-10,839
|
|
||
|
AAMI
754
Acadian Asset Management
AAMI
$2.5B
| – | – |
-4,731
|
|
||
755
Antero Resources
AR
$11.4B
| – | – |
-6,004
|
|
||
756
Accuray
ARAY
$35.9M
| – | – |
-40,550
|
|
||
757
Archrock
AROC
$6.45B
| – | – |
-7,659
|
|
||
758
BioCryst Pharmaceuticals
BCRX
$2.44B
| – | – |
-21,672
|
|
||
759
Barclays
BCS
$77.9B
| – | – |
-36,519
|
|